AstraZeneca has been cleared to include cardiovascular and kidney outcomes data on the label of its type 2 diabetes therapy Forxiga in the EU which could help it challenge rival drugs in the SGLT2 ...

Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction, after getting a green light from the EMA's human medicine committee.

Abstract: Classification of pathological images is the basis for automatic cancer diagnosis. Despite that deep learning methods have achieved remarkable performance, they heavily rely on labeled data, ...

ITMO scientists, together with colleagues from the Almazov National Research Medical Center, have figured out how to quickly identify cardiac fibrosis using deep learning. To do this, they developed ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Investing.com -- CoreWeave Inc (NASDAQ:CRWV) shares dropped 6% Thursday following a report from The Verge that characterized the company as being at "the heart of the AI bubble," raising questions ...

Novo Nordisk’s pill to treat diabetes can now be marketed for its cardiovascular benefits, following approval by European regulators. Rybelsus, an oral version of the semaglutide drug that is the main ...

Mastering tenses is fundamental to effective communication in English. This comprehensive guide provides an in-depth exploration of various tenses, offering clear explanations, illustrative examples, ...

New Delhi: A new study published in The Lancet Public Health has found that placing salt warning labels on restaurant menus can encourage people to make healthier food choices by reducing their ...

Bayer AG BAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The regulatory body approved finerenone for the treatment of adult patients with ...

Private-label products are becoming more attractive to consumers. What trends have you noticed at your company and in the wider market? Inflation and the need to save money have contributed to ...